Invention Grant
US08945833B2 Method for determining drug resistance mutations in any of the non-structural protein regions NS3 to NS5B of hepatitis C virus (HCV) for genotypes 1 to 6
有权
用于确定基因型1至6的丙型肝炎病毒（HCV）的非结构蛋白质NS3至NS5B的任何非结构蛋白质区域中的耐药突变的方法
- Patent Title: Method for determining drug resistance mutations in any of the non-structural protein regions NS3 to NS5B of hepatitis C virus (HCV) for genotypes 1 to 6
- Patent Title (中): 用于确定基因型1至6的丙型肝炎病毒（HCV）的非结构蛋白质NS3至NS5B的任何非结构蛋白质区域中的耐药突变的方法
-
Application No.: US13122614Application Date: 2009-10-06
-
Publication No.: US08945833B2Publication Date: 2015-02-03
- Inventor: Lieven Jozef Stuyver , Diana Koletzki , Jan Martin Berke , Ina Isabel Vandenbroucke , Leen Roger Vijgen
- Applicant: Lieven Jozef Stuyver , Diana Koletzki , Jan Martin Berke , Ina Isabel Vandenbroucke , Leen Roger Vijgen
- Priority: EP08165949 20081006
- International Application: PCT/EP2009/062986 WO 20091006
- International Announcement: WO2010/040756 WO 20100415
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12Q1/70
Abstract:
The present invention relates to a method for determining drug resistance mutations in any of the non-structural protein regions NS3 to NS5B of Hepatitis C Virus (HCV) for genotypes 1 to 6, more in particular for subtype specific genotypes 1a, 1b, 2a, 2b, 3a, 4a and 4d.
Public/Granted literature
Information query
